BECTON DICKINSON & CO BDX
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1963-09-25
BECTON DICKINSON & CO statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 11.8% | 11.9% | 10.9% | 12.1% | 11.8% |
| Net margin | 7.7% | 8.4% | 7.7% | 9.4% | 10.9% |
| FCF margin | 12.2% | 15.5% | 10.9% | 7.9% | 18.0% |
| Return on assets | 3.0% | 3.0% | 2.8% | 3.4% | 3.9% |
| Return on equity | 6.6% | 6.6% | 5.8% | 7.0% | 8.8% |
| Debt / equity | 0.69× | 0.69× | 0.57× | 0.55× | 0.72× |
| Current ratio | 1.11 | 1.17 | 1.31 | 1.04 | 1.33 |
| Revenue growth | 8.2% | 4.2% | 2.7% | -1.4% | 19.0% |
Source: SEC EDGAR filings · CIK 0000010795 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.